- Sweeping Vietnam internet law comes into force
- Pope kicks off Christmas under shadow of war
- Catholics hold muted Christmas mass in Indonesia's Sharia stronghold
- Japan's top diplomat in China to address 'challenges'
- Thousands attend Christmas charity dinner in Buenos Aires
- Demand for Japanese content booms post 'Shogun'
- As India's Bollywood shifts, stars and snappers click
- Mystery drones won't interfere with Santa's work: US tracker
- Djokovic eyes more Slam glory as Swiatek returns under doping cloud
- Australia's in-form Head confirmed fit for Boxing Day Test
- Brazilian midfielder Oscar returns to Sao Paulo
- 'Wemby' and 'Ant-Man' to make NBA Christmas debuts
- US agency focused on foreign disinformation shuts down
- On Christmas Eve, Pope Francis launches holy Jubilee year
- 'Like a dream': AFP photographer's return to Syria
- Chiefs seek top seed in holiday test for playoff-bound NFL teams
- Panamanians protest 'public enemy' Trump's canal threat
- Cyclone death toll in Mayotte rises to 39
- Ecuador vice president says Noboa seeking her 'banishment'
- Leicester boss Van Nistelrooy aware of 'bigger picture' as Liverpool await
- Syria authorities say armed groups have agreed to disband
- Maresca expects Man City to be in title hunt as he downplays Chelsea's chancs
- Man Utd boss Amorim vows to stay on course despite Rashford row
- South Africa opt for all-pace attack against Pakistan
- Guardiola adamant Man City slump not all about Haaland
- Global stocks mostly higher in thin pre-Christmas trade
- Bethlehem marks sombre Christmas under shadow of war
- NASA probe makes closest ever pass by the Sun
- 11 killed in blast at Turkey explosives plant
- Indonesia considers parole for ex-terror chiefs: official
- Global stocks mostly rise in thin pre-Christmas trade
- Postecoglou says Spurs 'need to reinforce' in transfer window
- Le Pen says days of new French govt numbered
- Global stocks mostly rise after US tech rally
- Villa boss Emery set for 'very difficult' clash with Newcastle
- Investors swoop in to save German flying taxi startup
- How Finnish youth learn to spot disinformation
- South Korean opposition postpones decision to impeach acting president
- 12 killed in blast at Turkey explosives plant
- Panama leaders past and present reject Trump's threat of Canal takeover
- Hong Kong police issue fresh bounties for activists overseas
- Saving the mysterious African manatee at Cameroon hotspot
- India consider second spinner for Boxing Day Test
- London wall illuminates Covid's enduring pain at Christmas
- Poyet appointed manager at South Korea's Jeonbuk
- South Korea's opposition vows to impeach acting president
- The tsunami detection buoys safeguarding lives in Thailand
- Teen Konstas to open for Australia in Boxing Day India Test
- Asian stocks mostly up after US tech rally
- US panel could not reach consensus on US-Japan steel deal: Nippon
Nobel chemistry winner sees engineered proteins solving tough problems
Whether it's battling tumors or breaking down plastic, American scientist David Baker, co-recipient of this year's Nobel Prize in Chemistry, has an answer: engineering proteins that don't naturally exist -- a concept once dismissed as "crazy."
Today, proteins with novel functions are flowing steadily out of his lab, with an endless list of potential applications ranging from ultra-targeted therapies to the development of new vaccines.
"Across the range of problems that we face today in medicine and health, sustainability, energy, and technology, I think the potential for protein design is enormous," Baker told AFP via video call from Seattle, hours after learning of his Nobel win alongside two other laureates.
Proteins are organic molecules that play a fundamental role in almost every function of living organisms, from muscle contraction and food digestion to neuron activation and more.
"The ones in nature evolved to solve all the problems that were faced during natural selection," explained the 62-year-old University of Washington professor.
"But humans face new problems today," added the biochemist and computational biologist.
"We're heating up the planet, so we need new solutions in ecology and sustainability. We live longer, so there's new diseases which are relevant, like Alzheimer's disease. There's new pathogens like coronavirus."
Rather than leave these problems up to evolution -- a "brutal" solution that would take a very, very long time -- "with new proteins, we can solve those problems, but in a very short time," he said.
- From fringe to mainstream -
All proteins are composed of chains of amino acids, whose sequence dictates their shape -- and ultimately their function.
For decades, scientists have tried to determine protein structures based on these amino acid sequences.
In the late 1990s, Baker made strides towards solving this problem with a computer software he developed called Rosetta.
His success prompted a shift his focus to the reverse approach: starting with a desired shape and using Rosetta to identify the corresponding amino acid sequence. This sequence can then be introduced into bacteria, which synthesize the new protein that can be harvested and studied.
In 2003, he published his breakthrough finding -- the creation of the first-ever protein not found in nature -- though it still lacked a defined function.
"Then we started trying to design proteins that actually would do useful things," Baker recalled. "And that's when people, I think, really started thinking it was crazy."
But "for the last 20 years -— and really, most recently, the last five years -— we've been able to make proteins that do all kinds of amazing things," he said. Rosetta meanwhile has been progressively improved to incorporate artificial intelligence.
"I think what's kind of funny now is that the lunatic fringe, which pretty much no one was doing, has now entered the mainstream," he added with a laugh.
- Keys that fit locks -
How do scientists decide what shape a new protein needs to achieve the desired function?
Baker gives the example of a tumor. "We know some protein that's on the surface of that tumor, and we know its shape. What we do is we design a protein that acts like a key fitting into a lock," he explained.
Another application: breaking down plastic. In this case, a protein is designed to attach itself to the plastic molecule, accompanied by chemical compounds to "cut" it.
In medicine, this technology has already been used in a Covid-19 vaccine approved in South Korea. Researchers are also exploring its potential to create new materials.
"In biology, we have tooth and bone, we have shells, which are made by proteins interacting with inorganic compounds like calcium carbonate or calcium phosphate," says Baker, envisioning proteins interacting with other compounds to create entirely new materials with unique properties.
Greenhouse gas capture, a universal flu vaccine, improved antivenom -- Baker's wish list goes on and on.
"As protein design becomes more powerful, I'm incredibly excited about all the problems that we will be able to solve."
A.Mahlangu--AMWN